
Bojesen and Petersen Biotech has developed bActivate - a new product to aid diagnosis and efficient antimicrobial therapy of problem mares with chronic subclinical uterine infections. bActivate has been developed by two Danish researchers following their discovery that up to 10% of all mares may have subclinical uterine infections and the adverse impact of such infections on mare fertility. Veterinarians at the world’s largest equine hospital in Kentucky have demonstrated that bActivate virtually restored the live-foal rates to normal and thus re-vitalized mares that had been given up for…
Annual Revenue$1M to $5M
Estimated OwnershipPrivateBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.